Welcome to
Lunatum Biotech - your preclinical CRO for orthopedics and gene medicine
We are preclinical CRO experts for joints, cartilage, bone, and tendon with a focus on osteoarthritis and rare bone diseases.
We are preclinical CRO experts for joints, cartilage, bone, and tendon with a focus on osteoarthritis and rare bone diseases.
"Lunatum Biotech’s expertise in musculoskeletal research, particularly in osteoarthritis, has been invaluable to us. Their use of advanced models and innovative approaches—integrating behavioral studies, imaging, and post-mortem analyses—delivers unparalleled insights into treatment efficacy. Their precision, scientific rigor, and transparency make them a trusted partner in advancing our projects. The Lunatum team was always mindful of our budget and consistently available for questions or updates."
Mari Anne Snow, CEO of
EASCRA BIOTECH, Inc.,
MassBioDrive Startup of the Year,
NASA and ISS National Lab
sponsored research on the ISS
Lunatum Biotech is your preclinical CRO orthopedics and your trusted partner in musculoskeletal drug discovery, specializing in preclinical development for joint, cartilage, bone, tendon, and muscle diseases. With decades of expertise and a focus on innovation, we help navigate the complexities of rare and common musculoskeletal disorders to develop impactful therapies.
For molecular therapy and gene delivery system developers, the growing field of musculoskeletal medicine offers vast opportunities. Our preclinical CRO expert team, each with 20+ years in orthopedic research, collaborates with you to identify high-impact disease indications and drive breakthroughs in treatment. Together, let's transform patient care and shape the future of medicine. We have a special focus on CRO osteoarthritis services and CRO bone services.
lab mouse
Why choose us?
Our expertise and experience
Lunatum Biotech is your reliable and innovative preclinical CRO and partner for preclinical research and development in the field of molecular musculoskeletal medicine and gene therapy. Our scientists use optimized techniques and work protocols for the isolation and in-depth analysis of on-target and off-target cells. Using a variety of innovative in-vitro modeling systems and in-vivo musculoskeletal research models, we provide crucial preclinical insights to companies working towards developing targeted drugs for the rapidly expanding orthopedic molecular medicine market.
Our specialization and commitment
Lunatum Biotech offers a comprehensive solution for the preclinical evaluation of pioneering therapy approaches, serving as your premier preclinical CRO partner in advancing medical progress. With expertise spanning the medical fields of orthopedics and sports medicine, trauma and reconstructive surgery, and rheumatology, we are committed to addressing the unmet needs of the pharmaceutical and biotech industry. At Lunatum Biotech, we aim to play a pivotal role in propelling the field of musculoskeletal therapies forward. Our special focus is on CRO osteoarthritis and CRO bone services.
Our motivation and communication
At Lunatum Biotech, we prioritize direct collaboration between our clients and seasoned lead scientists, ensuring responsive and transparent communication at every step of the project. Our hallmark is delivering scientific excellence promptly and within budget, setting us apart in the industry. With a team of highly motivated scientists who deeply comprehend your requirements, we are dedicated to advancing both your scientific goals and commercial success. Partner with Lunatum Biotech for a seamless journey towards achieving your objectives.
Selected models (but not limited to):
Selected preclinical CRO service packages:
Our array of preclinical CRO services encompasses:
We possess unparalleled preclinical CRO expertise regarding the following target tissues/organs:
We employ a variety of experimental methods, such as:
Contact us for further details regarding our continuously expanding preclinical CRO services.
The disorders listed below provide valuable insight into the numerous unmet treatment needs within musculoskeletal diseases. Please don't hesitate to contact us for in-depth discussions about target diseases, areas of research interests, and how Lunatum Biotech - as a preclinical CRO - can offer support in developing cures for these conditions. We are deeply committed to collaborating with you to make significant strides in the field of musculoskeletal medicine. We have a special focus on CRO osteoarthritis services and CRO bone services.
Osteoarthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis - Lunatum Biotech is a preclinical CRO orthopedics with a special focus on CRO osteoarthritis services
Osteoarthritis, cartilage defects, osteochondral defects, Diastrophic Dysplasia - Lunatum Biotech is a preclinical CRO orthopedics with a special focus on CRO osteoarthritis services
Osteoporosis, Osteogenesis Imperfecta (OI), Fibrous Dysplasia, Hypophosphatasia, Fibrodysplasia Ossificans Progressiva (FOP), Multiple Epiphyseal Dysplasia (MED), Osteonecrosis, bone tumors, bone metastasis, bone fractures, osseous non-unions, bone defects - Lunatum Biotech is a preclinical CRO orthopedics with a special focus on CRO bone services
Tendon ruptures, Tendinitis, Tendinopathy, chronic tendon degeneration, ligament tears
Sarcopenia, Duchenne Muscular Dystrophy, Myasthenia Gravis, Spinal Muscular Atrophy, Polymyalgia Rheumatica, Polymyositis, muscle injuries
Intervertebral Disc Disease
Oliver is the Chief Executive Officer and Founder of Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School and was an Instructor at the Center for Molecular Orthopedics; Oliver served as Head of Orthopedic Regenerative Medicine at the University of Munich LMU and was a Visiting Scientist at MIT; he has 25 + years of experience in musculoskeletal research and gene therapy.
Volker is the Medical Director and Co-Founder of Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School; Volker is an Orthopedic Surgeon and passionate scientist; he has 20 + years of experience in orthopedic research and gene medicine.
Fawzy serves as Chief Scientific Officer of Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School and was an Assistant Professor at Einstein College of Medicine; Fawzy has 25 + years of experience in molecular musculoskeletal medicine.
Lunatum Biotech, LLC - your preclinical CRO orthopedics with a focus on CRO osteoarthritis services and CRO bone services.
Please send us a message or call us!
Lunatum Biotech´s phone number:
(+1) 781 518 8894
Lunatum Biotech´s Email:
Lunatum Biotech´s address:
100 Cummings Center, Suite 451C
Beverly, MA 01915
USA